Individualized Minimum-Effective GLP-1 Dosing
Titrate each patient to benefit without crossing into avoidable side effects.
- Difficulty
- Moderate
- Time to result
- ~weeks to results
- Steps
- 5
- Confidence
- 99%
This dosing model replaces automatic escalation with patient-specific titration. The clinician first establishes why the GLP-1 is being considered, reviews the patient's metabolic condition and risks, and then chooses a conservative starting point. Response is judged by meaningful efficacy rather than by whether the patient has reached a standardized target dose. The dose remains below the threshold that causes nausea, exhaustion, severe appetite suppression, or inability to meet nutritional needs. If the current amount works, there is no requirement to increase it; if it does not, the clinician can adjust the amount or interval gradually. The framework treats microdosing as a genuinely individualized fraction of a conventional dose, not merely the standard starting dose relabeled as a microdose.
Origin
Extracted from Habits & Hustle, where Dr. Tyna Moore contrasted individualized GLP-1 prescribing with protocols that automatically double doses every four weeks.
Core principles
- 01Treat the individual rather than the standard dosing schedule.
- 02Use the smallest dose that produces meaningful benefit.
- 03Side effects are signals to reconsider dosing and management.
- 04Increase slowly instead of automatically following a fixed escalation protocol.
How to run it
- 1
Define the therapeutic purpose
Identify the patient's symptoms, metabolic status, family history, goals, and reason for considering a GLP-1. Confirm that the treatment is serving a defined purpose rather than following a trend.
Pro tip Document the specific outcomes that would count as meaningful efficacy.
Watch out Do not assume that everyone should use a GLP-1.
- 2
Choose an individualized starting point
Select a conservative dose based on the person in front of you rather than reflexively using the standard schedule. A true microdose may be only a fraction of the conventional starting dose.
Pro tip Account for metabolic health, sensitivity, affordability, and prior medication responses.
Watch out Calling the standard starting dose a microdose does not make it individualized.
- 3
Monitor benefit and tolerance
Track the intended outcome alongside nausea, fatigue, appetite suppression, nutrition, hydration, and functional capacity. Look for the point where benefit appears without making the patient's daily life worse.
Pro tip Use objective measures appropriate to the goal in addition to subjective reports.
Watch out Severe appetite suppression can cause malnutrition and muscle loss.
- 4
Stop at minimum efficacy
Hold the dose when it produces sufficient benefit. Do not escalate merely because a calendar-based protocol says it is time.
Pro tip A stable low dose can be preferable to a theoretically optimal dose the patient cannot tolerate.
Watch out More medication does not automatically produce a better long-term outcome.
- 5
Adjust dose or interval deliberately
If circumstances or response change, alter the dose, extend the interval, or temporarily cycle off under supervision. Reassess the full clinical picture after each change.
Pro tip Make one material adjustment at a time so its effect can be evaluated.
Watch out Do not improvise medication changes without qualified medical oversight.
In the wild
Moore described using the conventional protocol as a starting structure for her severely overweight and metabolically compromised father, but increasing it exceptionally slowly. It took approximately a year to reach only half of the maximum dose, where he was losing weight gradually and improving blood sugar without wasting away.
→ Meaningful metabolic and weight improvements with better tolerability and less risk of excessive tissue loss.
A lean patient with a cardiovascular risk goal begins below the conventional starting dose. The clinician holds that dose once objective markers improve and appetite remains sufficient for strength training and protein intake.
→ The patient receives a targeted benefit without unnecessary escalation or debilitating side effects.
Common mistakes
Relabeling standard dosing
Starting everyone at the standard dose and merely escalating more slowly is not the same as selecting an individualized microdose.
Escalating by calendar alone
Automatically doubling a dose every four weeks ignores whether the current dose is already effective or poorly tolerated.
Using nausea as proof of efficacy
Nausea and inability to eat are not required signs that the treatment is working; they may indicate excessive dosing.
Is it for you?
Best for
Clinicians and appropriately supervised patients seeking sustainable GLP-1 benefits with the lowest practical exposure.
Not ideal for
It is not appropriate for unsupervised self-prescribing or anyone requiring urgent treatment without individualized medical assessment.
From the transcript
“We titrate until we get minimal efficacy.”
“But we keep the dose this side of nausea.”
“I'm talking about using a fraction of that dose for someone who needs it.”
From the episode
Episode 393: Dr. Tyna Moore: Why Ozempic Should Be Microdosed, HRT Tips, Peptides for Metabolic Health + More
Dr. Tyna Moore